ADMA Biologics, Inc. (ADMA)
9.63
-1.70
(-15.00%)
USD |
NASDAQ |
Mar 25, 16:00
9.47
-0.16
(-1.66%)
After-Hours: 20:00
ADMA Biologics Cash from Investing (Quarterly) : -0.276M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AtriCure, Inc. | -2.602M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Ligand Pharmaceuticals, Inc. | -18.10M |
| ANI Pharmaceuticals, Inc. | -1.403M |
| Terns Pharmaceuticals, Inc. | 24.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 35.64M |
| Cash from Financing (Quarterly) | -9.118M |
| Free Cash Flow | 27.50M |
| Free Cash Flow Per Share (Quarterly) | 0.1409 |
| Free Cash Flow to Equity (Quarterly) | 37.60M |
| Free Cash Flow to Firm (Quarterly) | 35.67M |
| Free Cash Flow Yield | 1.16% |